Display, engineering, and applications of antigen-specific T cell receptors

Biomolecular Engineering

Volumn 24, Issue 4, 2007, Pages 361-373

  Richman, Sarah A ^a   Kranz, David M ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Antigens; High affinity T cell receptors; Monoclonal antibodies; Peptide major histocompatibility complex; T cell immunity; Tumor targeting

Indexed keywords

CELL IMMUNITY; CELL RECEPTORS; HISTOCOMPATIBILITY COMPLEX; TUMOR TARGETING;

HISTOLOGY; MONOCLONAL ANTIBODIES; PEPTIDES; PHARMACOKINETICS; PHYSIOLOGY;

ANTIGENS;

ADALIMUMAB; ANTIBODY CONJUGATE; ETANERCEPT; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; T CELL VACCINE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VACCINE; VIRUS ANTIGEN;

ADOPTIVE TRANSFER; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; BINDING AFFINITY; CANCER; CELL MIGRATION; CELL SURFACE; DRUG MECHANISM; ENGINEERING; GENE THERAPY; GENE TRANSFER; HISTOCOMPATIBILITY COMPLEX; HUMAN; IN VITRO STUDY; MAMMAL CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS;

LYMPHOKINES; PEPTIDE LIBRARY; PROTEIN ENGINEERING; RECEPTORS, ANTIGEN, T-CELL;

EID: 34548592046     PISSN: 13890344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bioeng.2007.02.009     Document Type: Review

References (98)

1. Altman J.D., Moss P.A.H., Goulder P.J.R., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMicheal A.J., and Davis M.M. Phenotypic analysis of antigen-specific T lymphocytes. Science 274 (1996) 94-96
2. Barbas C.F.I., Kang A.S., Lerner R.A., and Benkovic S.J. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 7978
3. Boder E.T., Midelfort K.S., and Wittrup K.D. Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 10701-10705
4. Boder E.T., and Wittrup K.D. Yeast surface display for screening combinatorial polypeptide libraries. Nat. Biotechnol. 15 (1997) 553-557
5. Boder E.T., and Wittrup K.D. Optimal screening of surface-displayed polypeptide libraries. Biotechnol. Prog. 14 (1998) 55-62
6. Boder E.T., and Wittrup K.D. Yeast surface display for directed evolution of protein expression, affinity, and stability. Methods Enzymol. 328 (2000) 430-444
7. Boon T., and Old L.J. Cancer tumor antigens. Curr. Opin. Immunol. 9 (1997) 681-683
8. Boulter J.M., Glick M., Todorov P.T., Baston E., Sami M., Rizkallah P., and Jakobsen B.K. Stable, soluble T-cell receptor molecules for crystallization and therapeutics. Protein Eng. 16 (2003) 707-711
9. Boulter J.M., and Jakobsen B.K. Stable, soluble, high-affinity, engineered T cell receptors: novel antibody-like proteins for specific targeting of peptide antigens. Clin. Exp. Immunol. 142 (2005) 454-460
10. Bowley D.R., Labrijn A.F., Zwick M.B., and Burton D.R. Antigen selection from an HIV-1 immune antibody library displayed on yeast yields many novel antibodies compared to selection from the same library displayed on phage. Protein Eng. Des. Sel. 20 (2007) 81-90
11. Buonpane R.A., Moza B., Sundberg E.J., and Kranz D.M. Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1. J. Mol. Biol. 353 (2005) 308-321
12. Chen J.L., Dunbar P.R., Gileadi U., Jager E., Gnjatic S., Nagata Y., Stockert E., Panicali D.L., Chen Y.T., Knuth A., Old L.J., and Cerundolo V. Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL. J. Immunol. 165 (2000) 948-955
13. Chlewicki L.K., Holler P.D., Monti B.C., Clutter M.A., and Kranz D.M. High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3. J. Mol. Biol. 346 (2005) 223-239
14. Churchill H.R., and Kranz D.M. Directed evolution of T-cell receptors for binding superantigens. In: Krakauer T. (Ed). Methods in Molecular Biology: Superantigen Protocols vol. 214 (2003) 87-99
15. Clackson T., Hoogenboom H.R., Griffiths A.D., and Winter G. Making antibody fragments using phage display libraries. Nature 352 (1991) 624-628
16. Cohen C.J., Zhao Y., Zheng Z., Rosenberg S.A., and Morgan R.A. Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability. Cancer Res. 66 (2006) 8878-8886
17. Colf, L.A., Bankovich, A.J., Hanick, N.A., Bowerman, N.A., Jones, L.L., Kranz, D.M., Garcia, K.C., in press. How a single T cell receptor recognizes both self and foreign MHC. Cell.
18. Daniels M.A., and Jameson S.C. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers. J. Exp. Med. 191 (2000) 335-346
19. Davis M.M., and Bjorkman P.J. T-cell antigen receptor genes and T-cell recognition. Nature 334 (1988) 395-402
20. Ding Y.H., Baker B.M., Garboczi D.N., Biddison W.E., and Wiley D.C. Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. Immunity 11 (1999) 45-56
21. Donermeyer D.L., Weber K.S., Kranz D.M., and Allen P.M. The study of high-affinity TCRs reveals duality in T cell recognition of antigen: specificity and degeneracy. J. Immunol. 177 (2006) 6911-6919
22. Dudley M.E., and Rosenberg S.A. Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat. Rev. Cancer 3 (2003) 666-675
23. Dudley M.E., Wunderlich J.R., Robbins P.F., Yang J.C., Hwu P., Schwartzentruber D.J., Topalian S.L., Sherry R., Restifo N.P., Hubicki A.M., Robinson M.R., Raffeld M., Duray P., Seipp C.A., Rogers-Freezer L., Morton K.E., Mavroukakis S.A., White D.E., and Rosenberg S.A. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298 (2002) 850-854
24. Dunn S.M., Rizkallah P.J., Baston E., Mahon T., Cameron B., Moysey R., Gao F., Sami M., Boulter J., Li Y., and Jakobsen B.K. Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity. Protein Sci. 15 (2006) 710-721
25. Eisen H.N. Specificity and degeneracy in antigen recognition: yin and yang in the immune system. Annu. Rev. Immunol. 19 (2001) 1-21
26. Evavold B.D., Williams S.G., Hsu B.L., Buus S., and Allen P.M. Complete dissection of the Hb(64-76) determinant using T helper 1, T helper 2 clones, and T cell hybridomas. J. Immunol. 148 (1992) 347
27. Feldhaus M., Siegel R., Opresko L., Coleman J.R., Weaver-Feldhaus J.M., Yeung Y.A., Cochran J.R., Heinzelman P., Colby D., Swers J., Graff C., Wiley H.S., and Wittrup K.D. Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library. Nat. Biotechnol. 21 (2003) 163-170
28. Foote J., and Eisen H.N. Breaking the affinity ceiling for antibodies and T cell receptors. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 10679-10681
29. Fujio K., Okamoto A., Araki Y., Shoda H., Tahara H., Tsuno N.H., Takahashi K., Kitamura T., and Yamamoto K. Gene therapy of arthritis with TCR isolated from the inflamed paw. J. Immunol. 177 (2006) 8140-8147
30. Garcia K.C., and Adams E.J. How the T cell receptor sees antigen-a structural view. Cell 122 (2005) 333-336
31. Garcia K.C., Degano M., Pease L.R., Huang M., Peterson P., Teyton L., and Wilson I.A. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 279 (1998) 1166-1172
32. Garcia K.C., Tallquist M.D., Pease L.R., Brunmark A., Scott C.A., Degano M., Stura E.A., Peterson P.A., Wilson I.A., and Teyton L. Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 13838-13843
33. Ho W.Y., Blattman J.N., Dossett M.L., Yee C., and Greenberg P.D. Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction. Cancer Cell 3 (2003) 431-437
34. Holler P.D., Chlewicki L.K., and Kranz D.M. TCRs with high affinity for foreign pMHC show self-reactivity. Nat. Immunol. 4 (2003) 55-62
35. Holler P.D., Holman P.O., Shusta E.V., O'Herrin S., Wittrup K.D., and Kranz D.M. In vitro evolution of a T cell receptor with high affinity for peptide/MHC. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 5387-5392
36. Holler P.D., and Kranz D.M. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity 18 (2003) 255-264
37. Holler P.D., Lim A.R., Cho B.K., Rund L.A., and Kranz D.M. CD8- T cell transfectants that express a high affinity T cell receptor exhibit enhanced peptide-dependent activation. J. Exp. Med. 194 8 (2001) 1043-1052
38. Holliger P., and Hudson P.J. Engineered antibody fragments and the rise of single domains. Nat. Biotechnol. 23 (2005) 1126-1136
39. Holt L.J., Herring C., Jespers L.S., Woolven B.P., and Tomlinson I.M. Domain antibodies: proteins for therapy. Trends Biotechnol. 21 (2003) 484-490
40. Hoogenboom H.R. Selecting and screening recombinant antibody libraries. Nat. Biotechnol. 23 (2005) 1105-1116
41. Hoogenboom H.R., Griffiths A.D., Johnson K.S., Chiswell D.J., Hudson P., and Winter G. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res. 19 (1991) 4133-4137
42. Howard M.C., Spack E.G., Choudhury K., Greten T.F., and Schneck J.P. MHC-based diagnostics and therapeutics-clinical applications for disease-linked genes. Immunol. Today 20 (1999) 161-165
43. Irvine D.J., Purbhoo M.A., Krogsgaard M., and Davis M.M. Direct observation of ligand recognition by T cells. Nature 419 (2002) 845-849
44. Jones L.L., Brophy S.E., Bankovich A.J., Colf L.A., Hanick N.A., Garcia K.C., and Kranz D.M. Engineering and characterization of a stabilized alpha1/alpha2 module of the class I major histocompatibility complex product Ld. J. Biol. Chem. 281 (2006) 25734-25744
45. Kersh G.J., Kersh E.N., Fremont D.H., and Allen P.M. High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling. Immunity 9 (1998) 817-826
46. Kessels H.W., de Visser K.E., Kruisbeek A.M., and Schumacher T.N. Circumventing T-cell tolerance to tumour antigens. Biologicals 29 (2001) 277-283
47. Kessels H.W., van Den Boom M.D., Spits H., Hooijberg E., and Schumacher T.N. Changing T cell specificity by retroviral T cell receptor display. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 14578-14583
48. Kieke M.C., Shusta E.V., Boder E.T., Teyton L., Wittrup K.D., and Kranz D.M. Selection of functional T cell receptor mutants from a yeast surface- display library. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 5651-5656
49. Kieke M.C., Sundberg E., Shusta E.V., Mariuzza R.A., Wittrup K.D., and Kranz D.M. High affinity T cell receptors from yeast display libraries block T cell activation by superantigens. J. Mol. Biol. 307 (2001) 1305-1315
50. Kotzin B.L., Leung D.Y.M., Kappler J., and Marrack P. Superantigens and their potential role in human disease. Adv. Immunol. 54 (1993) 99-166
51. Krogsgaard M., and Davis M.M. How T cells 'see' antigen. Nat. Immunol. 6 (2005) 239-245
52. Kuball J., Dossett M.L., Wolfl M., Ho W.Y., Voss R.H., Fowler C., and Greenberg P.D. Facilitating matched pairing and expression of TCR-chains introduced into human T-cells. Blood 109 (2006) 2331-2338
53. Kuball J., Schmitz F.W., Voss R.H., Ferreira E.A., Engel R., Guillaume P., Strand S., Romero P., Huber C., Sherman L.A., and Theobald M. Cooperation of human tumor-reactive CD4+ and CD8+ T cells after redirection of their specificity by a high-affinity p53A2.1-specific TCR. Immunity 22 (2005) 117-129
54. Laugel B., Boulter J.M., Lissin N., Vuidepot A., Li Y., Gostick E., Crotty L.E., Douek D.C., Hemelaar J., Price D.A., Jakobsen B.K., and Sewell A.K. Design of soluble recombinant T cell receptors for antigen targeting and T cell inhibition. J. Biol. Chem. 280 (2005) 1882-1892
55. Li Y., Moysey R., Molloy P.E., Vuidepot A.L., Mahon T., Baston E., Dunn S., Liddy N., Jacob J., Jakobsen B.K., and Boulter J.M. Directed evolution of human T-cell receptors with picomolar affinities by phage display. Nat. Biotechnol. 23 (2005) 349-354
56. Malchiodi E.L., Eisenstein E., Fields B.A., Ohlendorf D.H., Schlievert P.M., Karjalainen K., and Mariuzza R.A. Superantigen binding to a T cell receptor beta chain of known three-dimensional structure 182 (1995) 1833-1845
57. Marsh S.G.E., Parham P., and Barber L.D. The HLA Facts Book (2000), Academic Press, London
58. Maynard J., Adams E.J., Krogsgaard M., Petersson K., Liu C.W., and Garcia K.C. High-level bacterial secretion of single-chain alphabeta T-cell receptors. J. Immunol. Methods 306 (2005) 51-67
59. Maynard J., Petersson K., Wilson D.H., Adams E.J., Blondelle S.E., Boulanger M.J., Wilson D.B., and Garcia K.C. Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity. Immunity 22 (2005) 81-92
60. McCormick J.K., Tripp T.J., Llera A.S., Sundberg E.J., Dinges M.M., Mariuzza R.A., and Schlievert P.M. Functional analysis of the TCR binding domain of toxic shock syndrome toxin-1 predicts further diversity in MHC class II/superantigen/TCR ternary complexes. J. Immunol. 171 (2003) 1385-1392
61. Miles J.J., Silins S.L., and Burrows S.R. Engineered T cell receptors and their potential in molecular medicine. Curr. Med. Chem. 13 (2006) 2725-2736
62. Molloy P.E., Sewell A.K., and Jakobsen B.K. Soluble T cell receptors: novel immunotherapies. Curr. Opin. Pharmacol. 5 (2005) 438-443
63. Moreland L.W. Soluble tumor necrosis factor receptor (p75) fusion protein (ENBREL) as a therapy for rheumatoid arthritis. Rheum. Dis. Clin. North Am. 24 (1998) 579-591
64. Morgan R.A., Dudley M.E., Wunderlich J.R., Hughes M.S., Yang J.C., Sherry R.M., Royal R.E., Topalian S.L., Kammula U.S., Restifo N.P., Zheng Z., Nahvi A., de Vries C.R., Rogers-Freezer L.J., Mavroukakis S.A., and Rosenberg S.A. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314 (2006) 126-129
65. Moza B., Buonpane R.A., Zhu P., Herfst C.A., Rahman A.K., McCormick J.K., Kranz D.M., and Sundberg E.J. Long-range cooperative binding effects in a T cell receptor variable domain. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 9867-9872
66. Orr B.A., Carr L.M., Wittrup K.D., Roy E.J., and Kranz D.M. Rapid method for measuring ScFv thermal stability by yeast surface display. Biotechnol. Prog. 19 (2003) 631-638
67. Pancer Z., and Cooper M.D. The evolution of adaptive immunity. Annu. Rev. Immunol. 24 (2006) 497-518
68. Purbhoo M.A., Irvine D.J., Huppa J.B., and Davis M.M. T cell killing does not require the formation of a stable mature immunological synapse. Nat. Immunol. 5 (2004) 524-530
69. Purbhoo M.A., Sutton D.H., Brewer J.E., Mullings R.E., Hill M.E., Mahon T.M., Karbach J., Jager E., Cameron B.J., Lissin N., Vyas P., Chen J.L., Cerundolo V., and Jakobsen B.K. Quantifying and imaging NY-ESO-1/LAGE-1-derived epitopes on tumor cells using high affinity T cell receptors. J. Immunol. 176 (2006) 7308-7316
70. Rajpal A., Beyaz N., Haber L., Cappuccilli G., Yee H., Bhatt R.R., Takeuchi T., Lerner R.A., and Crea R. A general method for greatly improving the affinity of antibodies by using combinatorial libraries. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 8466-8471
71. Razai A., Garcia-Rodriguez C., Lou J., Geren I.N., Forsyth C.M., Robles Y., Tsai R., Smith T.J., Smith L.A., Siegel R.W., Feldhaus M., and Marks J.D. Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A. J. Mol. Biol. 351 (2005) 158-169
72. Richman, S.A., Healan, S.J., Weber, K.S., Donermeyer, D.L., Dossett, M.L., Greenberg, P.D., Allen, P.M., Kranz, D.M., 2006. Development of a novel strategy for engineering high-affinity proteins by yeast display. Protein Eng. Des. Sel., in press
73. Rosenberg S.A. Progress in human tumour immunology and immunotherapy. Nature 411 (2001) 380-384
74. Rudolph M.G., Stanfield R.L., and Wilson I.A. How TCRs bind MHCs, peptides, and coreceptors. Annu. Rev. Immunol. 24 (2006) 419-466
75. Scott J.K., and Smith G.P. Searching for peptide ligands with an epitope library. Science 249 (1990) 386-390
76. Seibel J.L., Wilson N., Kozono H., Marrack P., and Kappler J.W. Influence of the NH2-terminal amino acid of the T cell receptor alpha chain on major histocompatibility complex (MHC) class II + peptide recognition. J. Exp. Med. 185 (1997) 1919-1927
77. Sherman L.A., Hesse S.V., Irwin M.J., La Face D., and Peterson P. Selecting T cell receptors with high affinity for self-MHC by decreasing the contribution of CD8. Science 258 (1992) 815-818
78. Shusta E.V., Holler P.D., Kieke M.C., Kranz D.M., and Wittrup K.D. Directed evolution of a stable scaffold for T-cell receptor engineering. Nat. Biotechnol. 18 (2000) 754-759
79. Shusta E.V., Kieke M.C., Parke E., Kranz D.M., and Wittrup K.D. Yeast polypeptide fusion surface display levels predict thermal stability and soluble secretion efficiency. J. Mol. Biol. 292 (1999) 949-956
80. Spiotto M.T., Rowley D.A., and Schreiber H. Bystander elimination of antigen loss variants in established tumors. Nat. Med. 10 (2004) 294-298
81. Stanislawski T., Voss R.H., Lotz C., Sadovnikova E., Willemsen R.A., Kuball J., Ruppert T., Bolhuis R.L., Melief C.J., Huber C., Stauss H.J., and Theobald M. Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer. Nat. Immunol. 2 (2001) 962-970
82. Stemmer W.P.C. Rapid evolution of a protein in vitro by DNA shuffling. Nature 370 (1994) 389-391
83. Stokkers P.C., and Hommes D.W. New cytokine therapeutics for inflammatory bowel disease. Cytokine 28 (2004) 167-173
84. Sundberg E.J., Li H., Llera A.S., McCormick J.K., Tormo J., Schlievert P.M., Karjalainen K., and Mariuzza R.A. Structures of two streptococcal superantigens bound to TCR beta chains reveal diversity in the architecture of T cell signaling complexes. Structure (Camb.) 10 (2002) 687-699
85. Tallquist M.D., Yun T.J., and Pease L.R. A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity. J. Exp. Med. 184 (1996) 1017-1026
86. Tsimberidou A.M., Catovsky D., Schlette E., O'Brien S., Wierda W.G., Kantarjian H., Garcia-Manero G., Wen S., Do K.A., Lerner S., and Keating M.J. Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone. Cancer 107 (2006) 125-135
87. Udaka K., Tsomides T.J., and Eisen H.N. A naturally occurring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein. Cell 69 (1992) 989-998
88. Udaka K., Wiesmuller K., Kienle S., Jung G., and Walden P. Self-MHC-restricted peptides recognized by an alloreactive T-lymphocyte clone. J. Immunol. 157 (1996) 670-678
89. Utz U., Banks D., Jacobson S., and Biddison W.E. Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion. J. Virol. 70 (1996) 843-851
90. Wang L., Abbasi F., Gaigalas A.K., Vogt R.F., and Marti G.E. Comparison of fluorescein and phycoerythrin conjugates for quantifying CD20 expression on normal and leukemic B-cells. Cytometry B: Clin. Cytom. 70 (2006) 410-415
91. Wang L., Zhao Y., Li Z., Guo Y., Jones L.L., Kranz D.M., Mourad W., and Li H. Crystal structure of a complete ternary complex of TCR, superantigen and peptide-MHC. Nat. Struct. Mol. Biol. 14 (2007) 169-171
92. Wang Y., Rubtsov A., Heiser R., White J., Crawford F., Marrack P., and Kappler J.W. Using a baculovirus display library to identify MHC class I mimotopes. Proc. Natl. Acad. Sci. U.S.A. 10 (2005) 2476-2481
93. Weber K.S., Donermeyer D.L., Allen P.M., and Kranz D.M. Class II-restricted T cell receptor engineered in vitro for higher affinity retains peptide specificity and function. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 19033-19038
94. Weidanz J.A., Card K.F., Edwards A., Perlstein E., and Wong H.C. Display of functional αβ single-chain T-cell receptor molecules on the surface of bacteriophage. J. Immunol. Methods 221 (1998) 59-76
95. Winter G., Griffiths A.D., Hawkins R.E., and Hoogenboom H.R. Making antibodies by phage display technology. Annu. Rev. Immunol. 12 (1994) 433-455
96. Worn A., and Pluckthun A. Stability engineering of antibody single-chain Fv fragments. J. Mol. Biol. 305 (2001) 989-1010
97. Yee C., Thompson J.A., Byrd D., Riddell S.R., Roche P., Celis E., and Greenberg P.D. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 16168-16173
98. Zinkernagel R.M. The Nobel Lectures in Immunology. The Nobel Prize for Physiology or Medicine, 1996. Cellular immune recognition and the biological role of major transplantation antigens. Scand. J. Immunol. 46 (1997) 421-436